LOK YUN LOUISE SIN: Open Payments
NPI 1083209514 · RENTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,792 in 76 payments from 23 companies in 2025. Trend: 2023 $7,443 · 2024 $10,979 · 2025 $3,792
Food & beverage: $3,389Education: $403
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $764 |
| Astellas Pharma US Inc | 14 | $488 |
| AstraZeneca Pharmaceuticals LP | 8 | $431 |
| Daiichi Sankyo Inc. | 6 | $409 |
| ABBVIE INC. | 11 | $318 |
| Pharmacosmos Therapeutics Inc. | 2 | $253 |
| E.R. Squibb & Sons, L.L.C. | 3 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $141 |
| Agios Pharmaceuticals, Inc. | 1 | $139 |
| Incyte Corporation | 1 | $125 |
Products named: RYBREVANT, Vyloy, Enhertu, LYNPARZA, DATROWAY, EPKINLY, REBLOZYL, ERLEADA.
Industry payments across WA — which companies pay providers there.
